Evidence map›Paper›PMID 36100764›Full record

ArticleCellular and molecular life sciences : CMLS2022

Perilipin-2 limits remyelination by preventing lipid droplet degradation.

Melanie Loix, Elien Wouters, Sam Vanherle, Jonas Dehairs, James L McManaman, Hannelore Kemps, Johannes V Swinnen, Mansour Haidar, Jeroen F J Bogie, Jerome J A Hendriks

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. An Aqueous Extract ofInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Melanie LoixDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Elien WoutersDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Sam VanherleDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Jonas DehairsDepartment of Oncology, Laboratory of Lipid Metabolism and Cancer, LKI-Louvain Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium.
James L McManamanDepartment of Obstetrics and Gynaecology, School of Medicine, University of Colorado, Denver, USA.
Hannelore KempsDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Johannes V SwinnenDepartment of Oncology, Laboratory of Lipid Metabolism and Cancer, LKI-Louvain Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium.
Mansour Haidar *Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Jeroen F J Bogie *Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Jerome J A Hendriks *Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium. jerome.hendriks@uhasselt.be.ORCID http://orcid.org/0000-0002-7717-8582
National MS Center MelsbroekVIB-KU Leuven Center for Cancer Biology · BEUniversity of Colorado Denver · US

Funding

Fonds Wetenschappelijk Onderzoek 1141920NFonds Wetenschappelijk Onderzoek 1S15519N
6 · The paper itself

Abstract

Foamy macrophages and microglia containing lipid droplets (LDs) are a pathological hallmark of demyelinating disorders affecting the central nervous system (CNS). We and others showed that excessive accumulation of intracellular lipids drives these phagocytes towards a more inflammatory phenotype, thereby limiting CNS repair. To date, however, the mechanisms underlying LD biogenesis and breakdown in lipid-engorged phagocytes in the CNS, as well as their impact on foamy phagocyte biology and lesion progression, remain poorly understood. Here, we provide evidence that LD-associated protein perilipin-2 (PLIN2) controls LD metabolism in myelin-containing phagocytes. We show that PLIN2 protects LDs from lipolysis-mediated degradation, thereby impairing intracellular processing of myelin-derived lipids in phagocytes. Accordingly, loss of Plin2 stimulates LD turnover in foamy phagocytes, driving them towards a less inflammatory phenotype. Importantly, Plin2-deficiency markedly improves remyelination in the ex vivo brain slice model and in the in vivo cuprizone-induced demyelination model. In summary, we identify PLIN2 as a novel therapeutic target to prevent the pathogenic accumulation of LDs in foamy phagocytes and to stimulate remyelination.

Indexed as

Lipid DropletsRemyelinationLipidsMyelin SheathPerilipin-2LipidsPerilipin-2Foamy macrophagesInflammationLipid droplet associated proteinLipolysisLipophagy

Identifiers

PMID36100764
PMCPMC11803036
OpenAlexW4295761027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.